Share Facebook Twitter LinkedIn Pinterest Email Paysign projects 100% growth in pharma patient affordability revenue for 2025
InnovAge forecasts $1.05B-$1.085B revenue and $105M-$115M adjusted EBITDA for fiscal 2027 as it targets 5%-7.5% census growth (NASDAQ:INNV)September 9, 2026